Cargando…
Differentiation of Pseudoprogression from True Progressionin Glioblastoma Patients after Standard Treatment: A Machine Learning Strategy Combinedwith Radiomics Features from T(1)-weighted Contrast-enhanced Imaging
BACKGROUND: Based on conventional MRI images, it is difficult to differentiatepseudoprogression from true progressionin GBM patients after standard treatment, which isa critical issue associated with survival. The aim of this study was to evaluate the diagnostic performance of machine learning using...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860032/ https://www.ncbi.nlm.nih.gov/pubmed/33535988 http://dx.doi.org/10.1186/s12880-020-00545-5 |
_version_ | 1783646858262872064 |
---|---|
author | Sun, Ying-Zhi Yan, Lin-Feng Han, Yu Nan, Hai-Yan Xiao, Gang Tian, Qiang Pu, Wen-Hui Li, Ze-Yang Wei, Xiao-Cheng Wang, Wen Cui, Guang-Bin |
author_facet | Sun, Ying-Zhi Yan, Lin-Feng Han, Yu Nan, Hai-Yan Xiao, Gang Tian, Qiang Pu, Wen-Hui Li, Ze-Yang Wei, Xiao-Cheng Wang, Wen Cui, Guang-Bin |
author_sort | Sun, Ying-Zhi |
collection | PubMed |
description | BACKGROUND: Based on conventional MRI images, it is difficult to differentiatepseudoprogression from true progressionin GBM patients after standard treatment, which isa critical issue associated with survival. The aim of this study was to evaluate the diagnostic performance of machine learning using radiomics modelfrom T(1)-weighted contrast enhanced imaging(T(1)CE) in differentiating pseudoprogression from true progression after standard treatment for GBM. METHODS: Seventy-sevenGBM patients, including 51 with true progression and 26 with pseudoprogression,who underwent standard treatment and T(1)CE, were retrospectively enrolled.Clinical information, including sex, age, KPS score, resection extent, neurological deficit and mean radiation dose, were also recorded collected for each patient. The whole tumor enhancementwas manually drawn on the T(1)CE image, and a total of texture 9675 features were extracted and fed to a two-step feature selection scheme. A random forest (RF) classifier was trained to separate the patients by their outcomes.The diagnostic efficacies of the radiomics modeland radiologist assessment were further compared by using theaccuracy (ACC), sensitivity and specificity. RESULTS: No clinical features showed statistically significant differences between true progression and pseudoprogression.The radiomic classifier demonstrated ACC, sensitivity, and specificity of 72.78%(95% confidence interval [CI]: 0.45,0.91), 78.36%(95%CI: 0.56,1.00) and 61.33%(95%CI: 0.20,0.82).The accuracy, sensitivity and specificity of three radiologists’ assessment were66.23%(95% CI: 0.55,0.76), 61.50%(95% CI: 0.43,0.78) and 68.62%(95% CI: 0.55,0.80); 55.84%(95% CI: 0.45,0.66),69.25%(95% CI: 0.50,0.84) and 49.13%(95% CI: 0.36,0.62); 55.84%(95% CI: 0.45,0.66), 69.23%(95% CI: 0.50,0.84) and 47.06%(95% CI: 0.34,0.61), respectively. CONCLUSION: T(1)CE–based radiomics showed better classification performance compared with radiologists’ assessment.The radiomics modelwas promising in differentiating pseudoprogression from true progression. |
format | Online Article Text |
id | pubmed-7860032 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-78600322021-02-04 Differentiation of Pseudoprogression from True Progressionin Glioblastoma Patients after Standard Treatment: A Machine Learning Strategy Combinedwith Radiomics Features from T(1)-weighted Contrast-enhanced Imaging Sun, Ying-Zhi Yan, Lin-Feng Han, Yu Nan, Hai-Yan Xiao, Gang Tian, Qiang Pu, Wen-Hui Li, Ze-Yang Wei, Xiao-Cheng Wang, Wen Cui, Guang-Bin BMC Med Imaging Research Article BACKGROUND: Based on conventional MRI images, it is difficult to differentiatepseudoprogression from true progressionin GBM patients after standard treatment, which isa critical issue associated with survival. The aim of this study was to evaluate the diagnostic performance of machine learning using radiomics modelfrom T(1)-weighted contrast enhanced imaging(T(1)CE) in differentiating pseudoprogression from true progression after standard treatment for GBM. METHODS: Seventy-sevenGBM patients, including 51 with true progression and 26 with pseudoprogression,who underwent standard treatment and T(1)CE, were retrospectively enrolled.Clinical information, including sex, age, KPS score, resection extent, neurological deficit and mean radiation dose, were also recorded collected for each patient. The whole tumor enhancementwas manually drawn on the T(1)CE image, and a total of texture 9675 features were extracted and fed to a two-step feature selection scheme. A random forest (RF) classifier was trained to separate the patients by their outcomes.The diagnostic efficacies of the radiomics modeland radiologist assessment were further compared by using theaccuracy (ACC), sensitivity and specificity. RESULTS: No clinical features showed statistically significant differences between true progression and pseudoprogression.The radiomic classifier demonstrated ACC, sensitivity, and specificity of 72.78%(95% confidence interval [CI]: 0.45,0.91), 78.36%(95%CI: 0.56,1.00) and 61.33%(95%CI: 0.20,0.82).The accuracy, sensitivity and specificity of three radiologists’ assessment were66.23%(95% CI: 0.55,0.76), 61.50%(95% CI: 0.43,0.78) and 68.62%(95% CI: 0.55,0.80); 55.84%(95% CI: 0.45,0.66),69.25%(95% CI: 0.50,0.84) and 49.13%(95% CI: 0.36,0.62); 55.84%(95% CI: 0.45,0.66), 69.23%(95% CI: 0.50,0.84) and 47.06%(95% CI: 0.34,0.61), respectively. CONCLUSION: T(1)CE–based radiomics showed better classification performance compared with radiologists’ assessment.The radiomics modelwas promising in differentiating pseudoprogression from true progression. BioMed Central 2021-02-03 /pmc/articles/PMC7860032/ /pubmed/33535988 http://dx.doi.org/10.1186/s12880-020-00545-5 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Sun, Ying-Zhi Yan, Lin-Feng Han, Yu Nan, Hai-Yan Xiao, Gang Tian, Qiang Pu, Wen-Hui Li, Ze-Yang Wei, Xiao-Cheng Wang, Wen Cui, Guang-Bin Differentiation of Pseudoprogression from True Progressionin Glioblastoma Patients after Standard Treatment: A Machine Learning Strategy Combinedwith Radiomics Features from T(1)-weighted Contrast-enhanced Imaging |
title | Differentiation of Pseudoprogression from True Progressionin Glioblastoma Patients after Standard Treatment: A Machine Learning Strategy Combinedwith Radiomics Features from T(1)-weighted Contrast-enhanced Imaging |
title_full | Differentiation of Pseudoprogression from True Progressionin Glioblastoma Patients after Standard Treatment: A Machine Learning Strategy Combinedwith Radiomics Features from T(1)-weighted Contrast-enhanced Imaging |
title_fullStr | Differentiation of Pseudoprogression from True Progressionin Glioblastoma Patients after Standard Treatment: A Machine Learning Strategy Combinedwith Radiomics Features from T(1)-weighted Contrast-enhanced Imaging |
title_full_unstemmed | Differentiation of Pseudoprogression from True Progressionin Glioblastoma Patients after Standard Treatment: A Machine Learning Strategy Combinedwith Radiomics Features from T(1)-weighted Contrast-enhanced Imaging |
title_short | Differentiation of Pseudoprogression from True Progressionin Glioblastoma Patients after Standard Treatment: A Machine Learning Strategy Combinedwith Radiomics Features from T(1)-weighted Contrast-enhanced Imaging |
title_sort | differentiation of pseudoprogression from true progressionin glioblastoma patients after standard treatment: a machine learning strategy combinedwith radiomics features from t(1)-weighted contrast-enhanced imaging |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860032/ https://www.ncbi.nlm.nih.gov/pubmed/33535988 http://dx.doi.org/10.1186/s12880-020-00545-5 |
work_keys_str_mv | AT sunyingzhi differentiationofpseudoprogressionfromtrueprogressioninglioblastomapatientsafterstandardtreatmentamachinelearningstrategycombinedwithradiomicsfeaturesfromt1weightedcontrastenhancedimaging AT yanlinfeng differentiationofpseudoprogressionfromtrueprogressioninglioblastomapatientsafterstandardtreatmentamachinelearningstrategycombinedwithradiomicsfeaturesfromt1weightedcontrastenhancedimaging AT hanyu differentiationofpseudoprogressionfromtrueprogressioninglioblastomapatientsafterstandardtreatmentamachinelearningstrategycombinedwithradiomicsfeaturesfromt1weightedcontrastenhancedimaging AT nanhaiyan differentiationofpseudoprogressionfromtrueprogressioninglioblastomapatientsafterstandardtreatmentamachinelearningstrategycombinedwithradiomicsfeaturesfromt1weightedcontrastenhancedimaging AT xiaogang differentiationofpseudoprogressionfromtrueprogressioninglioblastomapatientsafterstandardtreatmentamachinelearningstrategycombinedwithradiomicsfeaturesfromt1weightedcontrastenhancedimaging AT tianqiang differentiationofpseudoprogressionfromtrueprogressioninglioblastomapatientsafterstandardtreatmentamachinelearningstrategycombinedwithradiomicsfeaturesfromt1weightedcontrastenhancedimaging AT puwenhui differentiationofpseudoprogressionfromtrueprogressioninglioblastomapatientsafterstandardtreatmentamachinelearningstrategycombinedwithradiomicsfeaturesfromt1weightedcontrastenhancedimaging AT lizeyang differentiationofpseudoprogressionfromtrueprogressioninglioblastomapatientsafterstandardtreatmentamachinelearningstrategycombinedwithradiomicsfeaturesfromt1weightedcontrastenhancedimaging AT weixiaocheng differentiationofpseudoprogressionfromtrueprogressioninglioblastomapatientsafterstandardtreatmentamachinelearningstrategycombinedwithradiomicsfeaturesfromt1weightedcontrastenhancedimaging AT wangwen differentiationofpseudoprogressionfromtrueprogressioninglioblastomapatientsafterstandardtreatmentamachinelearningstrategycombinedwithradiomicsfeaturesfromt1weightedcontrastenhancedimaging AT cuiguangbin differentiationofpseudoprogressionfromtrueprogressioninglioblastomapatientsafterstandardtreatmentamachinelearningstrategycombinedwithradiomicsfeaturesfromt1weightedcontrastenhancedimaging |